Form 8-K - Current report:
SEC Accession No. 0001193125-24-067919
Filing Date
2024-03-14
Accepted
2024-03-14 16:15:54
Documents
15
Period of Report
2024-03-08
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d785063d8k.htm   iXBRL 8-K 26307
2 EX-16.1 d785063dex161.htm EX-16.1 1630
  Complete submission text file 0001193125-24-067919.txt   147597

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA aclx-20240308.xsd EX-101.SCH 2838
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE aclx-20240308_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aclx-20240308_pre.xml EX-101.PRE 10804
16 EXTRACTED XBRL INSTANCE DOCUMENT d785063d8k_htm.xml XML 3494
Mailing Address 800 BRIDGE PARKWAY REDWOOD CITY CA 94065
Business Address 800 BRIDGE PARKWAY REDWOOD CITY CA 94065 240-327-0603
Arcellx, Inc. (Filer) CIK: 0001786205 (see all company filings)

IRS No.: 472855917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41259 | Film No.: 24750348
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)